27_02_2023 //
R&D Innovation
Osteoarthritis: among the infiltrative therapies, Biofarma Group patents the Vijoint HCC device
Scopri di più
03_02_2023 //
R&D Innovation
Prediabetes: Biofarma Group’s proposal to maintain normal blood glucose levels black
Scopri di più
25_01_2023 //
R&D Innovation
Mood supplements: taking care of mental well-being
Scopri di più
28_12_2022 //
R&D Innovation
Cardiovascular disease: a clinically proven supplement for cardiac support
Scopri di più
14_12_2022 //
R&D Innovation
Osteoporosis: two nutraceutical products from Biofarma Group to support “aging well”
Scopri di più
29_11_2022 //
R&D Innovation
Cannabis and anxiety: hemp for the main active ingredient of a supplement
Scopri di più
18_11_2022 //
R&D Innovation
Cognitive disorders: nutraceuticals to support memory and attention
Scopri di più
03_11_2022 //
R&D Innovation
Hyperuricemia: a nutraceutical can help fight it
Scopri di più
06_10_2022 //
R&D Innovation
Pre-hypertension: from Biofarma Group an innovative nutraceutical solution to counteract it
Scopri di più
28_07_2022 //
R&D Innovation
UTIs: Nutraceutical Business Review interviews Dr. De Seta, a specialist in obstetrics and gynecology
Scopri di più